Shunda Du
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC (NCT07639138) | Shunda Du | 2026-06-10 |
Track Shunda Du automatically
Every clearance here is in the API, with alerts when new ones post.